Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC28H25N3O4 |
InChIKeyHQQHYDSAYJUPSU-HOTGVXAUSA-N |
CAS Registry2650198-83-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 29 Sep 2011 |